In a milestone that underscores the power of sustained political will and rigorous public health strategy, the World Health Organization (WHO) has officially validated Tunisia as having eliminated trachoma as a public health problem. This achievement marks the conclusion of a decades-long battle against a disease that once afflicted more than half of the nation’s population, serving as a beacon of hope for other nations struggling against neglected tropical diseases (NTDs).
Trachoma, caused by the bacterium Chlamydia trachomatis, has historically been the world’s leading infectious cause of blindness. Its elimination in Tunisia is not merely a clinical success; it is a testament to the country’s ability to weave together primary healthcare, social development, and community engagement to eradicate a disease of poverty.
The Magnitude of the Achievement: Main Facts
For much of the 20th century, trachoma was a pervasive and devastating reality in Tunisia, particularly within the country’s southern provinces. Characterized by repeated infections that cause the eyelids to scar and turn inward—leading to excruciating pain and irreversible blindness—the disease thrived in environments with limited access to water, sanitation, and hygiene.
The WHO’s validation signifies that Tunisia has met stringent international benchmarks:
- Trachomatous Trichiasis (TT): The prevalence of the blinding stage of the disease among those aged 15 and older is now below 0.2%—a level considered “unknown to the health system.”
- Trachomatous Inflammation-Follicular (TF): The prevalence of the active, inflammatory stage in children aged 1–9 years has been reduced to below 5% in every formerly endemic district.
- Surveillance: The nation has successfully implemented a robust, sustainable surveillance system capable of identifying and managing any potential new cases, ensuring the disease does not re-emerge.
Tunisia is now the 31st country globally to receive this validation, and the 14th country in the WHO Eastern Mediterranean Region to eliminate at least one neglected tropical disease.
A Century of Struggle: The Chronology of Elimination
The path to this victory was not instantaneous. It was the result of a multi-generational commitment that evolved alongside the country’s own development.
Mid-20th Century: The Endemic Burden
In the early to mid-1900s, trachoma was rampant, affecting at least 50% of the Tunisian population. It was an entrenched health crisis that disproportionately impacted the most vulnerable, marginalized communities. Addressing it required more than just medical intervention; it required a fundamental shift in the socioeconomic fabric of the country.
The Implementation of the SAFE Strategy
Central to Tunisia’s success was the adoption of the WHO-recommended SAFE strategy, a comprehensive, four-pronged framework that allowed the Ministry of Health to tackle the disease from every angle:
- Surgery: Targeted at individuals with advanced, blinding stages of the disease.
- Antibiotics: Mass distribution campaigns to clear the bacterial infection from the population.
- Facial Cleanliness: Community-led initiatives to promote hygiene and reduce the spread of the pathogen.
- Environmental Improvement: A massive, long-term national push to improve water and sanitation infrastructure, effectively cutting off the primary transmission routes.
Institutional Integration
Over the following decades, the Ministry of Health integrated eye care directly into primary health care and school health programs. By embedding the fight against trachoma into the daily operations of the national health system, the country ensured that monitoring and prevention were not temporary projects, but permanent functions of the state.
Supporting Data and Technical Framework
The success of the Tunisian model lies in its alignment with the WHO’s 2021–2030 roadmap for neglected tropical diseases. The elimination process was supported by the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020), which provided the technical scaffolding for the country’s efforts.
The transition from an endemic state to a post-elimination state is supported by rigorous data collection. The Ministry of Health worked closely with international partners to conduct regular screening and treatment campaigns. These campaigns were backed by scientific evidence, ensuring that resources were directed toward the regions of highest risk.
The "post-validation" phase is already operational. Tunisia has established a surveillance system that includes continuous training for health professionals. This ensures that if the Chlamydia trachomatis bacterium is detected, the national health system can trigger an immediate, localized response, preventing the resurgence of the disease.
Voices of Leadership: Official Responses
The international and national response to this milestone has been one of universal praise, highlighting the interdisciplinary nature of the achievement.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the achievement, noting: “Eliminating trachoma shows what long-term political commitment, strong primary health care, and teamwork can do. Tunisia has proven that even the world’s leading infectious cause of blindness can be overcome.”
Echoing this sentiment, Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, emphasized the consistency of the effort: “This is a major achievement that reflects sustained and consistent national commitment over many years and shows what is possible when a country remains focused on addressing preventable causes of blindness.”
Dr. Mustapha Ferjani, Minister of Health of Tunisia, highlighted the role of the national workforce: “This milestone is the result of decades of coordinated national efforts, with the dedication of generations of health-care professionals, local communities who worked tirelessly to expand access to care, strengthen prevention and improve eye health across the country.”
Finally, Dr. Ahmed Zouiten, Acting WHO Representative in Tunisia, underscored the partnership aspect: “This milestone stands as a strong demonstration of how science, evidence-based programming, and coordinated technical support can overcome neglected tropical diseases every time and everywhere.”
Global Implications and Future Outlook
The validation of Tunisia’s success carries significant weight for the global health agenda. As part of the Sustainable Development Goals (SDGs), the elimination of NTDs is a priority for the international community.
The Model for Other Nations
Tunisia’s success provides a blueprint for other nations currently battling NTDs. It proves that:
- Infrastructure matters: Improving water and sanitation is as critical as surgical intervention.
- Integration is key: Eye health must be a standard component of primary health care, not a siloed vertical program.
- Sustainability is the goal: The creation of a post-elimination surveillance system is the final, and perhaps most important, step in the process.
The Wider Context of Neglected Tropical Diseases
Trachoma is often referred to as a "disease of poverty." It is caused by poor sanitation and limited access to clean water, often perpetuating a cycle where those suffering from the disease are unable to work or attend school, thereby remaining in poverty. By breaking this cycle, Tunisia has not only improved the physical health of its citizens but has also contributed to the socioeconomic empowerment of its most vulnerable regions.
While Tunisia celebrates this victory, the global community looks toward 2030, the revised target date for the worldwide elimination of trachoma. The success in Tunis provides a powerful psychological and practical boost to the remaining endemic countries.
Moving Forward
Tunisia’s accomplishment is a reminder that the eradication of ancient, devastating diseases is possible when the machinery of the state—from the central government to local community health workers—is aligned with international technical expertise.
The battle against trachoma is not merely about ridding the world of a specific bacterium; it is about reclaiming human potential. With this milestone, Tunisia has taken a definitive step toward a future where preventable blindness is a memory of the past, and a more equitable, healthy society is the reality for all.
Editor’s Note: Understanding Trachoma
Trachoma is an eye infection caused by the bacterium Chlamydia trachomatis. It is transmitted through personal contact (via contaminated hands or clothing) and by flies that have been in contact with discharge from the eyes or nose of an infected person. Without treatment, repeated infection causes severe scarring of the inner eyelid, which leads to the eyelashes turning inward (trichiasis). This causes the lashes to scratch the cornea, leading to pain, permanent scarring, and eventually, blindness.
The WHO’s GET2020 alliance continues to support governments and NGOs in their efforts to scale up the SAFE strategy, providing a framework for surveillance and control that has already seen dozens of countries reach the threshold for elimination. Tunisia’s victory is a major marker in this ongoing global campaign.
About the Author
